{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05869643",
            "orgStudyIdInfo": {
                "id": "STP-POC-001"
            },
            "organization": {
                "fullName": "ST Pharm Co., Ltd.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Clinical Trial of STP0404 in Adults With HIV-1 Infection",
            "officialTitle": "A Phase 2a, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Investigate the Antiviral Effect, Safety, Tolerability, and Pharmacokinetics of STP0404 in Adults With HIV-1 Infection",
            "therapeuticArea": [
                "Infectious Diseases"
            ],
            "study": "a-clinical-trial-of-in-adults-with-hiv-infection"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2023-05-23",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-10-21",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-11-21",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-04-17",
            "studyFirstSubmitQcDate": "2023-05-16",
            "studyFirstPostDateStruct": {
                "date": "2023-05-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-27",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "ST Pharm Co., Ltd.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate the antiviral effect, safety, tolerability, and pharmacokinetics of STP0404 in adult participants living with Human Immunodeficiency Virus Type 1 (HIV-1) infection."
        },
        "conditionsModule": {
            "conditions": [
                "HIV-1-infection"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "maskingDescription": "Initial randomization to Cohort 1 or 2 will not be blinded. However, randomization within each cohort to either receive STP0404 or matching placebo is blinded.",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 36,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1 STP0404",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Low-dose STP0404 (Pirmitegravir)"
                    ]
                },
                {
                    "label": "Cohort 1",
                    "type": "PLACEBO_COMPARATOR",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "Cohort 2 STP0404",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Medium-dose STP0404 (Pirmitegravir)"
                    ]
                },
                {
                    "label": "Cohort 2",
                    "type": "PLACEBO_COMPARATOR",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "Cohort 3 STP0404",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: High-dose STP0404 (Pirmitegravir)"
                    ]
                },
                {
                    "label": "Cohort 3",
                    "type": "PLACEBO_COMPARATOR",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Low-dose STP0404 (Pirmitegravir)",
                    "description": "Once daily, oral capsule taken after breakfast",
                    "armGroupLabels": [
                        "Cohort 1 STP0404"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Medium-dose STP0404 (Pirmitegravir)",
                    "description": "Once daily, oral capsule taken after breakfast",
                    "armGroupLabels": [
                        "Cohort 2 STP0404"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "High-dose STP0404 (Pirmitegravir)",
                    "description": "Once daily, oral capsule taken after breakfast",
                    "armGroupLabels": [
                        "Cohort 3 STP0404"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Matching placebo capsule, taken orally once daily after breakfast",
                    "armGroupLabels": [
                        "Cohort 1",
                        "Cohort 2",
                        "Cohort 3"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "HIV-1 RNA copies change in plasma",
                    "description": "Ratio of change in plasma HIV-1 RNA from baseline to Day 11 following a 10-day treatment period at each dose level.",
                    "timeFrame": "Day 1, Day 11"
                },
                {
                    "measure": "Total Number of Adverse Events (AEs) occurring through Day 11",
                    "description": "Cumulative number of AEs occurring from Day 1 through Day 11 at each dose level and placebo in treatment-na\u00efve adults with HIV-1 infection, regardless of treatment discontinuation, and use of prohibited medications. The severity of the AE will be rated as per the Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events Corrected Version 2.1, July 2017. These will be descriptively summarized.",
                    "timeFrame": "Through day 11"
                },
                {
                    "measure": "Total Number of Serious Adverse Events (SAEs) occurring through Day 11",
                    "description": "Cumulative number of SAEs occurring from Day 1 through Day 11 at each dose level and placebo in treatment-na\u00efve adults with HIV-1 infection, regardless of treatment discontinuation, use of prohibited medications, and death are included in the endpoint. These will be descriptively summarized.",
                    "timeFrame": "Through day 11"
                },
                {
                    "measure": "Mean area under the concentration-time curve from zero to 24 hours (AUC0-24h)",
                    "timeFrame": "Day 1, Day 10"
                },
                {
                    "measure": "Mean observed maximum concentration after administration (Cmax)",
                    "timeFrame": "Day 1, Day 10"
                },
                {
                    "measure": "Mean time to reach Cmax (Tmax)",
                    "timeFrame": "Day 1, Day 10"
                },
                {
                    "measure": "Mean observed concentration at 24 hours after administration (C24h)",
                    "timeFrame": "Day 2, Day 4, Day 7, Day10, Day 11"
                },
                {
                    "measure": "Mean area under the concentration-time curve to infinite time (AUCinf)",
                    "timeFrame": "Day 10"
                },
                {
                    "measure": "Mean area under the concentration-time curve to time t (AUCt)",
                    "timeFrame": "Day 10"
                },
                {
                    "measure": "Mean terminal half-life (t1/2)",
                    "timeFrame": "Day 10"
                },
                {
                    "measure": "Mean apparent oral clearance (CL/F)",
                    "timeFrame": "Day 10"
                },
                {
                    "measure": "Mean apparent volume of distribution (Vd/F)",
                    "timeFrame": "Day 10"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "HIV-1 RNA copies change in plasma from baseline to post-dose timepoints",
                    "timeFrame": "Day 1, Day 2, Day 4, Day 7, Day 10, Day 11"
                },
                {
                    "measure": "HIV-1 RNA change in plasma from baseline to nadir over 11 days.",
                    "timeFrame": "Day 1 pre-dose, Day 11"
                },
                {
                    "measure": "Plasma HIV-1 RNA rate of decline over 11 days",
                    "timeFrame": "Day 1, Day 2, Day 4, Day 7, Day 10, Day 11"
                },
                {
                    "measure": "Number of participants with HIV-1 RNA <400 copies/mL",
                    "description": "descriptive statistics.",
                    "timeFrame": "Day 1, Day 2, Day 4, Day 7, Day 10, Day 11"
                },
                {
                    "measure": "Number of participants with HIV-1 RNA <50 copies/mL",
                    "timeFrame": "Day 1, Day 2, Day 4, Day 7, Day 10, Day 11"
                },
                {
                    "measure": "CD4+ cell count change",
                    "timeFrame": "Day 1, Day 11"
                },
                {
                    "measure": "STP0404 exposure-efficacy relationship in plasma HIV-1 RNA copies / CD4+ cell count",
                    "timeFrame": "Day 1, Day 11"
                },
                {
                    "measure": "Emergence of drug resistance mutations.",
                    "timeFrame": "Screening, Day 1, Day 4, Day 7, Day 11"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Have a confirmed HIV-1 infection in the documented medical record or at screening.\n* Have never received any ARTs (i.e., treatment-na\u00efve) before screening or only received one ARV regimen (2 or 3 drugs) at least 12 weeks before screening and/or received any monotherapy \u226410 days in a clinical trial setting at least 12 weeks before screening. Participants with a documented history of PrEP and/or PEP therapy but discontinued at least 8 weeks prior to screening are also eligible for inclusion.\n* Have a CD4+ cell count \u2265200 cells/mm3 at screening.\n\nExclusion Criteria:\n\n* Have a hepatitis B surface antigen or positive hepatitis C virus antibody at screening. An HCV confirmation (HCV RNA test) will be performed at a central laboratory if the HCV antibodies screening result is positive. If the HCV RNA test result is negative, the participant will be eligible.\n* Have a positive drug screen for amphetamines, barbiturates, cocaine, opiates, benzodiazepines, heroin, or phencyclidine. However, if in the opinion of the investigator, positive drug screen results may be due to prescription medication for therapeutic purposes (e.g., prescription Adderall for ADHD), eligibility decision shall rely on the investigator's medical judgment and should be documented.\n* Have a history of regular alcohol consumption, defined as an average weekly intake of \\>14 drinks (males) or \\>7 drinks (females), within 6 months of screening and/or has positive alcohol screen at screening and baseline.\n* Have received the following treatments as PrEP or PEP (\u22651 dose) prior to screening: monoclonal antibodies, HIV-1 maturation inhibitors, and long-acting INSTIs (such as cabotegravir).\n* Pregnant or lactating females.\n* Have a history of clinically relevant pancreatitis or hepatitis within the previous 6 months.\n* Participant received any allosteric HIV-1 integrase inhibitor (ALLINI, \u22651 dose) and/or received any long-acting ARVs (marketed or investigational, \u22651 dose) prior to screening.\n* Have previously failed an INSTIs-containing regimen.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "locations": [
                {
                    "facility": "Kaiser Permenente Los Angeles Medical Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90027",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "William Towner, MD",
                            "role": "CONTACT",
                            "phone": "323-783-8977",
                            "email": "William.j.towner@kp.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Ruane Clinical Research, Inc.",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90036",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Peter Ruane, MD",
                            "role": "CONTACT",
                            "phone": "323-954-0400",
                            "phoneExt": "1111",
                            "email": "pjruane@ruaneclinicalresearch.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Midway Immunology and Research Center",
                    "status": "RECRUITING",
                    "city": "Fort Pierce",
                    "state": "Florida",
                    "zip": "34982",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Moti Ramgopal, MD",
                            "role": "CONTACT",
                            "phone": "772-595-9830",
                            "email": "mramgopal@midwayresearch.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.44671,
                        "lon": -80.32561
                    }
                },
                {
                    "facility": "Schiff Center for Liver Diseases/University of Miami",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136-2107",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dushyantha Jayaweera, MD",
                            "role": "CONTACT",
                            "phone": "786-300-6747",
                            "email": "djayawee@med.miami.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Orlando Immunology Center",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32803",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Edwin DeJesus, MD",
                            "role": "CONTACT",
                            "phone": "407-647-3960",
                            "phoneExt": "2107",
                            "email": "edejesus@oicorlando.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "USF Health South Tampa Center for Advanced Healthcare",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33602-3511",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Casanas Beata, MD",
                            "role": "CONTACT",
                            "phone": "813-844-4187",
                            "email": "beata@usf.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Be Well Medical Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Berkley",
                    "state": "Michigan",
                    "zip": "48072",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Paul Benson",
                            "role": "CONTACT",
                            "phone": "248-544-9300",
                            "email": "DRPAULBENSON@DOCTORBEWELL.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.50309,
                        "lon": -83.18354
                    }
                },
                {
                    "facility": "Saint Michael's Medical Center",
                    "status": "RECRUITING",
                    "city": "Newark",
                    "state": "New Jersey",
                    "zip": "07102",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jihad Slim, MD",
                            "role": "CONTACT",
                            "phone": "973-877-5162",
                            "email": "jsmdsmmc@gmail.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.73566,
                        "lon": -74.17237
                    }
                },
                {
                    "facility": "South Jersey Infectious Disease",
                    "status": "RECRUITING",
                    "city": "Somers Point",
                    "state": "New Jersey",
                    "zip": "08244",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christopher Lucasti",
                            "role": "CONTACT",
                            "phone": "609-927-6662",
                            "email": "Infect123@aol.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.31762,
                        "lon": -74.5946
                    }
                },
                {
                    "facility": "North Shore University Hospital",
                    "status": "RECRUITING",
                    "city": "Manhasset",
                    "state": "New York",
                    "zip": "11030-3816",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Joseph McGowan, MD",
                            "role": "CONTACT",
                            "phone": "516-562-4280",
                            "email": "jmcgowan@northwell.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.79788,
                        "lon": -73.69957
                    }
                },
                {
                    "facility": "Atrium Health Wake Forest Baptist Medical Center - PPDS",
                    "status": "RECRUITING",
                    "city": "Winston-Salem",
                    "state": "North Carolina",
                    "zip": "27157",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "John Williamson, PharmD",
                            "role": "CONTACT",
                            "phone": "336-713-3431",
                            "email": "johnwill@wakehealth.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.09986,
                        "lon": -80.24422
                    }
                },
                {
                    "facility": "St Hope Foundation, Inc",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Bellaire",
                    "state": "Texas",
                    "zip": "77401",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "James Sims III",
                            "role": "CONTACT",
                            "phone": "713-839-7111",
                            "email": "drsims@offeringhope.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.70579,
                        "lon": -95.45883
                    }
                },
                {
                    "facility": "North Texas Infectious Diseases Consultants, P.A.",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75246",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mezgebe Berhe",
                            "role": "CONTACT",
                            "phone": "214-823-2533",
                            "email": "mezgebe.berhe@ntidc.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000003141",
                    "term": "Communicable Diseases"
                },
                {
                    "id": "D000015658",
                    "term": "HIV Infections"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000086982",
                    "term": "Blood-Borne Infections"
                },
                {
                    "id": "D000015229",
                    "term": "Sexually Transmitted Diseases, Viral"
                },
                {
                    "id": "D000012749",
                    "term": "Sexually Transmitted Diseases"
                },
                {
                    "id": "D000016180",
                    "term": "Lentivirus Infections"
                },
                {
                    "id": "D000012192",
                    "term": "Retroviridae Infections"
                },
                {
                    "id": "D000012327",
                    "term": "RNA Virus Infections"
                },
                {
                    "id": "D000014777",
                    "term": "Virus Diseases"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000007153",
                    "term": "Immunologic Deficiency Syndromes"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3522",
                    "name": "Acquired Immunodeficiency Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M18250",
                    "name": "HIV Infections",
                    "asFound": "HIV-1 Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "asFound": "Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "asFound": "Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M2593",
                    "name": "Blood-Borne Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M15558",
                    "name": "Sexually Transmitted Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17933",
                    "name": "Sexually Transmitted Diseases, Viral",
                    "relevance": "LOW"
                },
                {
                    "id": "M18640",
                    "name": "Lentivirus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M15026",
                    "name": "Retroviridae Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15149",
                    "name": "RNA Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M10199",
                    "name": "Immunologic Deficiency Syndromes",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4314",
                    "name": "Antiviral Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}